What This Report Will Provide?
HPV diagnostics market also formed one of the major market segment in infectious disease diagnostics market. HPV infections can be prevented, if diagnosed in the early stages. Pap tests are the most preferred tests to detect cervical cancer. Rapid HPV diagnostics and real-time PCR are the most advanced methods which have 95% sensitivity to HPV and cover a broad range of
[170 Pages Report]The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%.
Major Growth Boosters:
Growth in this market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589
Growth in the influenza market can be attributed to the rising prevalence of influenza, growth in research funding for influenza diagnostics, and rising demand for faster diagnosis and control of influenza. Advancements in technologies such as PCR and proteomics and significant growth prospects in developing countries are also expected to offer growth opportunities for players in the influenza diagnostics market
Critical questions the report answers:
- Where will all these developments take the industry in the long term?
- What are the upcoming trends for the infectious disease diagnostics market?
- Which segment provides the most opportunity for growth?
- Who are the leading vendors operating in this market?
- What are the opportunities for new market entrants?
Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589
By product and service, assays, kits and reagents segment to record the highest CAGR during the forecast period
Increased accessibility and the increasing number of IDD tests conducted are the key drivers for this segment. Globally, the volume of IDD tests is increasing mainly due to the rising geriatric population; increasing prevalence of infectious diseases; increased variety of reagents available and analytical techniques employed; and the continuous launch of newer, faster, and more reliable products.
Regional Growth Analysis:
The global healthcare consulting services market was dominated by North America, followed by Europe in 2017. Factors such as increasing M&A activity, pricing pressure on pharmaceutical companies are driving the growth of the healthcare consulting services market in this region. Asia Pacific, however, is estimated to register the highest CAGR during the forecast period due to the increasing need for remote care and telemedicine in rural areas in the region.